Early Diagnosis and Management of Gynecological Malignancies
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 15 September 2024 | Viewed by 47
Special Issue Editor
Interests: gynecological malignancies
Special Issue Information
Dear Colleagues,
Gynecological malignancies, including ovarian, cervical, uterine, and vulvar cancers, are a significant health concern worldwide. Early diagnosis and management of gynecological cancer play a crucial role in improving patient outcomes and reducing morbidity and mortality associated with these cancers. In recent years, there have been significant advances in understanding the risk factors, screening methods, diagnostic tools, and treatment options for gynecological malignancies, which have contributed to improving the rates of earlier detection and creating management strategies. The main goal of early diagnosis of gynecological malignancies is to identify the disease at an early stage when it is most treatable, thus improving patient survival rates and overall prognosis.
In this Special Issue, we would like to welcome contributions that will include original research articles (clinical and preclinical), reviews, or shorter perspective articles that emphasize the benefits and pitfalls of adjuvant and neoadjuvant therapies in gynecological cancer patients. Topics including, but not limited to, articles referring to the early detection of endometrial cancer pathology, pre-invasive and invasive forms of cervical cancer, pre-operative assessment of suspicious ovarian masses, and early diagnosis of vulvar cancer with an emphasis on their impact on survival outcomes and patient-reported outcomes, including quality of life, are welcome in this Special Issue.
We hope that leading experts will share their perspectives on the clinical management and outcomes of patients with gynecological cancer, contributing to our current knowledge with novel evidence that will provide the groundwork for further research.
Dr. Vasileios Pergialiotis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ovarian cancer
- cervical cancer
- uterine cancer
- vulvar cancer
- early diagnosis
- morbidity and mortality
- prognosis
